The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Blog I

Ionis VP Medical Affairs Successfully Placed by TCG

September 21, 2021
Ionis Pharmaceuticals has a 30-year track record of perfecting and advancing RNA-targeted drug discovery and development and is now expanding its commercialization capabilities. That expansion… Continue Reading →

High Expectations, Inspired By Patients and Fueled By Innovation

September 14, 2021
With a pipeline of more than 40 medicines, Ionis Pharmaceuticals is using its groundbreaking antisense therapies to bring better health and healing to millions of people. As clinical development and commercialization efforts continue to accelerate, Ionis works with The Chase Group to find leaders and executives who share a passion for helping patients, strive for excellence, and dare to dream big. Continue Reading →

The Chase Group Secures SVP, Regulatory for Atsena Therapeutics in Impressive Timeframe

September 8, 2021
After a comprehensive executive search that was completed in less than six weeks, The Chase Group is pleased to announce the placement of Dr. Molly… Continue Reading →

TCG Retained to Identify Vice President, Manufacturing/Supply Chain

September 3, 2021
Ventria Bioscience has partnered with The Chase Group to continue building its leadership team. The company’s technology is time-proven, with more than ten years of… Continue Reading →

Delivering Better Cancer Outcomes With the Best Teams

September 3, 2021
Checkmate Pharmaceuticals, a clinical stage immuno-oncology company, is focused on pioneering new medicines for combating melanoma, non-melanoma skin cancers, and head and neck cancer. Dr. James Wooldridge, Chief Medical Officer, has partnered with The Chase Group on executive search projects because of the thoroughness, productivity, and expert evaluations he receives from Chase as he builds out his clinical development and regulatory affairs teams at this fast-moving startup. Continue Reading →

Successful Collaboration Results in VP Finance Placement at Ionis

September 2, 2021
The Chase Group (TCG) is pleased to announce the successful recruitment of James Haney as the Vice President of Finance at Ionis Pharmaceuticals. Haney joins… Continue Reading →

The Chase Group and Biologics Consulting Continue Successful Collaboration

August 6, 2021
The Chase Group is pleased to announce the completion of a search for the Business Development Lead for Biologics Consulting. Kris Kraihanzel will contribute to… Continue Reading →

Alexza Pharmaceuticals Partnership Continues with Quality Assurance Leadership Search

August 4, 2021
Alexza Pharmaceuticals continues to partner with The Chase Group to secure a Senior Director/Head, Quality Assurance. The Chase Group is currently seeking quality assurance professionals… Continue Reading →

Atsena Therapeutics Retains The Chase Group to Identify Head of Regulatory

July 28, 2021
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company… Continue Reading →

Ventria Continues Partnership with The Chase Group to Find Agronomy Operations Leader

July 27, 2021
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an… Continue Reading →
© Copyright 1993-2021 The Chase Group; All Rights Reserved.